X0609 4 2026-08-05 0 0002131524 Braveheart Bio, Inc. BRVE 0001706399 Chimovits Erez false C/O BRAVEHEART BIO, INC. ONE LETTERMAN DR., BLDG. A, SUITE A4-300 SAN FRANCISCO CA 94129 1 0 1 0 0 Stock Option (Right to Buy) 18 2026-08-05 4 A 0 30000 0 A 2036-08-04 Common Stock 30000 30000 D The shares underlying the stock option will vest in full upon the earlier of (i) August 5, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer through such vesting date. Pursuant to an agreement with OrbiMed Advisors LLC, the Reporting Person is obligated to transfer any securities issued under any such stock options or other awards, or the economic benefit thereof to OrbiMed Advisors LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments IX, LP. /s/ James Paul Rickey, Attorney-in-Fact 2026-08-07